107 related articles for article (PubMed ID: 32912129)
1. Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs.
Patel P; Patel M
Recent Pat Nanotechnol; 2021; 15(2):154-164. PubMed ID: 32912129
[TBL] [Abstract][Full Text] [Related]
2. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
Gunawan M; Boonkanokwong V
Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications.
Alatawi HM; Alhwiti SS; Alsharif KA; Albalawi SS; Abusaleh SM; Sror GK; Qushawy M
Recent Pat Nanotechnol; 2024; 18(2):179-189. PubMed ID: 38197417
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration.
Anwar W; Dawaba HM; Afouna MI; Samy AM; Rashed MH; Abdelaziz AE
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33142816
[TBL] [Abstract][Full Text] [Related]
5. Lipid Nanoparticles as Carriers for Bioactive Delivery.
Dhiman N; Awasthi R; Sharma B; Kharkwal H; Kulkarni GT
Front Chem; 2021; 9():580118. PubMed ID: 33981670
[TBL] [Abstract][Full Text] [Related]
6. Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug.
Bao Z; Yung F; Hickman RJ; Aspuru-Guzik A; Bannigan P; Allen C
Drug Deliv Transl Res; 2024 Jul; 14(7):1872-1887. PubMed ID: 38158474
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting.
Rajoriya V; Gupta R; Vengurlekar S; Surendra Singh U
Int J Pharm; 2024 Apr; 655():123986. PubMed ID: 38493842
[TBL] [Abstract][Full Text] [Related]
8. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances.
Kumar V; Nair SC
Recent Pat Biotechnol; 2024; 18(1):2-21. PubMed ID: 38205772
[TBL] [Abstract][Full Text] [Related]
9. Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.
Preeti ; Sambhakar S; Saharan R; Narwal S; Malik R; Gahlot V; Khalid A; Najmi A; Zoghebi K; Halawi MA; Albratty M; Mohan S
Saudi Pharm J; 2023 Dec; 31(12):101870. PubMed ID: 38053738
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies.
Elmowafy M; Al-Sanea MM
Saudi Pharm J; 2021 Sep; 29(9):999-1012. PubMed ID: 34588846
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications.
Seo Y; Lim H; Park H; Yu J; An J; Yoo HY; Lee T
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986633
[TBL] [Abstract][Full Text] [Related]
12. Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.
Jacob S; Nair AB; Shah J; Gupta S; Boddu SHS; Sreeharsha N; Joseph A; Shinu P; Morsy MA
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335909
[TBL] [Abstract][Full Text] [Related]
13. Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts.
Fernandes F; Dias-Teixeira M; Delerue-Matos C; Grosso C
Nanomaterials (Basel); 2021 Feb; 11(3):. PubMed ID: 33668341
[TBL] [Abstract][Full Text] [Related]
14. Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects.
Scioli Montoto S; Muraca G; Ruiz ME
Front Mol Biosci; 2020; 7():587997. PubMed ID: 33195435
[TBL] [Abstract][Full Text] [Related]
15. Emerging Lipid-based Carriers for Systematic Utilization in the Pharmaceutical and Biomedical Sciences: A Review.
N Kendre P; R Kayande D; P Pote A; B Kanthale S; G Prajapati B; Kendre Y; Jain S
Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38284709
[TBL] [Abstract][Full Text] [Related]
16. Solid Lipid Nanoparticles as Carriers of Natural Phenolic Compounds.
Borges A; Freitas V; Mateus N; Fernandes I; Oliveira J
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33076501
[TBL] [Abstract][Full Text] [Related]
17. Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer.
Ying K; Bai B; Gao X; Xu Y; Wang H; Xie B
Front Bioeng Biotechnol; 2021; 9():670124. PubMed ID: 34307319
[TBL] [Abstract][Full Text] [Related]
18. A Novel, Nontoxic and Scalable Process to Produce Lipidic Vehicles.
Naziris N; Pippa N; Demetzos C
Materials (Basel); 2020 Nov; 13(21):. PubMed ID: 33171678
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
[TBL] [Abstract][Full Text] [Related]
20. Recent advancement in bioeffect, metabolism, stability, and delivery systems of apigenin, a natural flavonoid compound: challenges and perspectives.
Chen P; Chen F; Guo Z; Lei J; Zhou B
Front Nutr; 2023; 10():1221227. PubMed ID: 37565039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
